Retrospective study shows biodegradable pancreatic stents reduce pancreatitis rates in high-risk groups, suggesting improved patient outcomes.
Biodegradable pancreatic stent placement is technically safe, effective, and associated with significant cost savings and reduced patient/healthcare burden by negating the need for further procedures. Observed PEP rates were consistent with those reported in high-risk cohorts.
No takes yet. Share an insight, caveat, or question.
McGarrigle et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: